Hikma Pharmaceuticals Aktie
23,00
EUR
+0,60
EUR
+2,68
%
21,34
CHF
+0,05
CHF
+0,24
%
Werbung
Hikma Pharmaceuticals Aktie Analyse
14.12.12 | Hikma Pharmaceuticals overweight | Morgan Stanley | |
15.10.12 | Hikma Pharmaceuticals overweight | J.P. Morgan Cazenove | |
10.10.11 | Hikma Pharmaceuticals buy | Citigroup Corp. | |
21.07.09 | Hikma Pharmaceuticals | Global Biotech Investing |
Werbung
Werbung